Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation
Florian Haller, Evgeny A. Moskalev, Sarina Kuck, Matthias Bieg, Christa Winkelmann, Sarina Müller, Stephan Ihrler, Bruno Märkl, Roland Eils, Stefan Wiemann, Heinrich Iro, Arndt Hartmann, Abbas Agaimy
Abstract
Haller, Florian MD; Moskalev, Evgeny A. PhD; Kuck, Sarina MSc; Bieg, Matthias MSc; Winkelmann, Christa; Müller, Sarina K. MD; Ihrler, Stephan MD; Märkl, Bruno MD; Eils, Roland PhD; Wiemann, Stefan PhD; Iro, Heinrich MD; Hartmann, Arndt MD; Agaimy, Abbas MD Author Information
Topics & Concepts
ImmunostainingAcinic cell carcinomaDownregulation and upregulationPathologyPhilosophyBiologyImmunohistochemistrySalivary glandMedicineGeneticsGeneMucoepidermoid carcinomaNuclear Receptors and SignalingCancer-related gene regulationProtein Degradation and Inhibitors